Houston NICU’s Human Milk Fortifier Cuts Deadly Gut Disease Rates

At St. Joseph Medical Center’s downtown neonatal intensive care unit (NICU) in Houston, Texas, a strategic shift in nutritional practices has significantly reduced the incidence of a life-threatening gut disease in premature infants. The introduction of a human milk–based fortifier has led to a dramatic drop in cases of necrotizing enterocolitis (NEC) from as high as 11% to below 1% this year. This change is enhancing the survival odds for some of the most vulnerable patients in the hospital.

According to reports from FOX 26 Houston, St. Joseph Medical Center has collaborated with Prolacta Bioscience to implement a fortifier derived from pasteurized donor breast milk. NICU nurse manager Angela Hermes emphasized the importance of this change, stating, “We can take care of 29 babies here in our NICU,” underlining the profound impact on families facing the challenges of prematurity.

The Chief Nursing Officer, Vincent Gore, attributed the significant decline in NEC cases to the introduction of this new fortifier. Hospital officials highlighted that the focus is on preventing complications associated with prematurity, rather than simply reacting after infants become ill.

Understanding the Shift to Human Milk Fortifiers

Human milk–based fortifiers serve as concentrated supplements that enhance the nutritional intake of premature infants. These products increase calories, protein, and minerals while eliminating cow-milk proteins often found in traditional fortifiers. Prolacta Bioscience, the partner organization, specializes in 100% human milk–based products and has documented significant reductions in NEC rates in hospitals that have adopted exclusive human milk diets.

A large multicenter cohort study, along with other peer-reviewed research, has shown declines in both NEC occurrences and mortality rates. For further insights, individuals can refer to the multicenter study available on PubMed.

The Risks Associated with Necrotizing Enterocolitis

Necrotizing enterocolitis primarily affects premature and very low birth-weight infants, posing serious health risks that can escalate quickly to bowel perforation, sepsis, and even death. Medical analyses indicate that mortality rates among the smallest infants diagnosed with NEC can range from 30% to 50%. Systematic reviews place the overall mortality rate for NEC in the mid-20s percentage, with particularly heightened risks when surgical intervention is necessary, as highlighted in studies published by Pediatric Surgery International.

This alarming track record reinforces the significance of tailored feeding protocols and donor milk programs in NICUs, which are critical components in efforts to mitigate the incidence of NEC.

Families of premature infants at St. Joseph’s NICU, located at 1401 St. Joseph Parkway, are encouraged to engage with their care teams regarding nutrition plans, donor milk options, and feeding protocols. As the hospital continues to monitor outcomes and refine its approach, the focus remains on improving the care provided to its smallest patients.

For additional information about St. Joseph Medical Center and its services, families can visit the hospital’s official website, as well as access the original reporting by FOX 26 Houston.